🎉 Thrilled to announce that our paper “Evaluating Artificial Intelligence-Assisted Prostate Biparametric MRI Interpretation: An International Multireader Study” has been selected as the Best of AJR in the GU category for 2025! 🏆
Huge congrats to David Gelikman @davidgelikman, who led this incredible work, and to our amazing collaborators! 👏🙌
David Gelikman, Enis C. Yilmaz, Stephanie Harmon, Erich Huang, Julie An, Sena Azamat, Yan Mee Law, Daniel Margolis, Jamie Marko, Valeria Panebianco, Ömer Tarık Esengür, Yue Lin, Mason Belue, Sonia Gaur, Marco Bicchetti, Ziyue Xu, Jesse Tetreault, Dong Yang, Daguang Xu, Nathan Lay, Sandeep Gurram, Joanna Shih, Maria Merino, Rosina Lis, Peter Choyke, Brad Wood, Peter Pinto
@eniscy@DrSHarmon@yuexlin@OTEsengur@BelueMason@lawyanmee@AJR_Radiology
#ProstateCancer #ArtificialIntelligence #Radiology
https://t.co/pHadWFeh6H
Millions of men could benefit from faster scan to diagnose prostate cancer. The new MRI scan takes between 15-20 minutes and is just as accurate as the standard 40 minute scan.
Find out more: https://t.co/L3s8csMLQC
Picture credit: Channel 4 News
Great opportunity to learn how to interpret prostate MRI using PI-RADS and many other scoring systems! Led by experts @VioletaCatala and @giga_fra 👇
https://t.co/e3DviITzH2
Are we ready for quantitative prostate MRI? Find out what @DoctorMargolis et al. think about available evidence in this informative article @AJR_Radiology 👇
This review article discusses the evidence supporting the use of quantitative techniques in prostate MRI for cancer detection and tissue characterization and highlights the challenges that need to be addressed before widespread clinical adoption.https://t.co/EvvdHdqSfc
The Prostate Imaging for Recurrence Reporting (PI-RR) system standardizes MRI performance and interpretation after prostatectomy or radiation therapy and is an essential reference for radiologists in standardizing reporting of recurrent prostate cancer. https://t.co/8rLeQSVn2x
New insights show MRI at Biopsy 2 helps detect prostate cancer progression—even in patients with prior MRI-informed biopsies. But don’t skip the biopsy! Both targeted and systematic cores are key to accurate diagnosis. #TheVoiceofUrology#AUA
🔗 More: https://t.co/c6jYLDTIaz
Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial - ScienceDirect https://t.co/2KErFwbhhO
🎉Happy to share our new publication “Evaluating Artificial Intelligence–Assisted Prostate Biparametric MRI Interpretation: An International Multireader Study”
https://t.co/pHadWFeOWf
🥇Congratulations to @davidgelikman@DrSHarmon@eniscy our excellent team and collaborators from 🇺🇸🇮🇹🇹🇷🇸🇬 for this excellent work👍
#ProstateCancer #ArtificialIntelligence #ProstateMRI #CancerResearch #TeamScience
🎉Happy to share our new publication “Evaluating Artificial Intelligence–Assisted Prostate Biparametric MRI Interpretation: An International Multireader Study”
https://t.co/pHadWFeOWf
🥇Congratulations to @davidgelikman@DrSHarmon@eniscy our excellent team and collaborators from 🇺🇸🇮🇹🇹🇷🇸🇬 for this excellent work👍
#ProstateCancer #ArtificialIntelligence #ProstateMRI #CancerResearch #TeamScience
We are proud to announce the launch of AI-QUAL™, an innovative new feature in our flagship QP-Prostate platform, designed to automate prostate MR image quality assessment using PI-QUAL v2 guidelines.
👉https://t.co/gdfvlqIbDw
#MedicalImaging#AIinHealthcare#ProstateCancer
Viewpoint: Prostate cancer screening is shifting toward a more beneficial and less harmful approach by using MRI-targeted strategies, which reduce unnecessary biopsies and overdiagnosis. https://t.co/FsfSs3xmkG @IvoSchootsNL
Excited to share this work authored by superstar💫@EmilyKnott7 et al. in @Abdominal_Rad describing the initial results from our improvement journey during the @RadiologyACR Prostate MR Image Quality Improvement Collaborative @SocietyAbdRad@CleClinicMD
👉https://t.co/xAqaprSD8k
X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere.
The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc@theNCI@US_FDA and dedicated my career to help men and their families suffering from PCa
@nytimes@WSJ@FoxNews@CNN@NBCNews@Reuters@ASCO@PCFnews @DeptofDefense
🔥Restriction Spectrum Imaging as a quantitative biomarker for prostate cancer with reliable positive predictive value | @JUrology@AmerUrological
https://t.co/fxuRgQQRQk
Congrats @TylerSbrt and team.